Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial
Fields of Study & Subjects
Retinal and Optic Conditions
Acute Ischemic Stroke Management
Peripheral Artery Disease Management
Publication details
- Journal / source
- The Lancet
- Publisher
- Elsevier BV
- Volume
- 407
- Issue
- 10530
- Pages
- 763–772
- Publication date
- 1 February 2026
- Language
- EN